[go: up one dir, main page]

DE60137506D1 - Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose - Google Patents

Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose

Info

Publication number
DE60137506D1
DE60137506D1 DE60137506T DE60137506T DE60137506D1 DE 60137506 D1 DE60137506 D1 DE 60137506D1 DE 60137506 T DE60137506 T DE 60137506T DE 60137506 T DE60137506 T DE 60137506T DE 60137506 D1 DE60137506 D1 DE 60137506D1
Authority
DE
Germany
Prior art keywords
arthrosis
treatment
cyclodextrins
polysulpated
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60137506T
Other languages
English (en)
Inventor
Eric Maximilien Veys
August Lodewijk Verbruggen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Gent
Original Assignee
Universiteit Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Gent filed Critical Universiteit Gent
Application granted granted Critical
Publication of DE60137506D1 publication Critical patent/DE60137506D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60137506T 2000-07-17 2001-07-12 Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose Expired - Lifetime DE60137506D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009272A FR2811572B1 (fr) 2000-07-17 2000-07-17 Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose
PCT/FR2001/002253 WO2002005826A1 (fr) 2000-07-17 2001-07-12 Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose

Publications (1)

Publication Number Publication Date
DE60137506D1 true DE60137506D1 (de) 2009-03-12

Family

ID=8852528

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60137506T Expired - Lifetime DE60137506D1 (de) 2000-07-17 2001-07-12 Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose

Country Status (13)

Country Link
US (1) US6930098B2 (de)
EP (1) EP1301192B1 (de)
JP (1) JP4960568B2 (de)
AT (1) ATE421326T1 (de)
AU (1) AU2001276437A1 (de)
CA (1) CA2416369C (de)
CY (1) CY1108980T1 (de)
DE (1) DE60137506D1 (de)
DK (1) DK1301192T3 (de)
ES (1) ES2322794T3 (de)
FR (1) FR2811572B1 (de)
PT (1) PT1301192E (de)
WO (1) WO2002005826A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2297516T3 (es) * 2003-12-02 2008-05-01 Universiteit Gent Uso de alginato polisulfatado en matrices celulares.
BRPI0918873A2 (pt) * 2008-09-22 2015-12-01 Arcarios B V pollissulfatos de ciclodextrina carboxialquilados úteis como medicamentos.
WO2011117317A2 (en) 2010-03-24 2011-09-29 Arcarios Bv Substituted cyclodextrin derivatives useful as intermediates for producing biologically active materials
ITMI20132116A1 (it) 2013-12-18 2015-06-19 Apharm Srl Associazione di glicosamminoglicani e ciclodestrine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247535A (en) * 1979-11-05 1981-01-27 American Cyanamid Company Modified cyclodextrin sulfate salts as complement inhibitors
US4258180A (en) * 1979-11-05 1981-03-24 American Cyanamid Company C6-Modified cyclodextrin sulfate salts as complement inhibitors
JP2806454B2 (ja) * 1988-01-19 1998-09-30 武田薬品工業株式会社 脈管形成阻止剤
EP0447171B1 (de) * 1990-03-15 1994-11-02 Tanabe Seiyaku Co., Ltd. Polysulfat eines Cyclodextrinderivates und Verfahren zu dessen Herstellung
US5100878A (en) * 1990-05-07 1992-03-31 American Maize-Products Company Blocking the effect of teratogens on a fetus
DK0569383T3 (da) * 1991-01-30 1996-10-14 Hoechst Ag Lavmolekylære, sulfaterede poly-beta-2,6-fructofuranosaner og deres anvendelse til behandling af degenerative ledsygdomme
FI942166A7 (fi) * 1991-11-11 1994-07-08 The Trustees Of The Univ Of Menetelmiä restenoosin ehkäisemiseksi
DE69621528T2 (de) * 1995-02-07 2003-01-16 Shiseido Co. Ltd., Tokio/Tokyo Anti-inflamatorische agenzien
US5843920A (en) * 1996-09-16 1998-12-01 Biocell Technology, Llc Anionic saccharides for extraction of anti-angiogenic protein from cartilage

Also Published As

Publication number Publication date
CA2416369C (fr) 2008-07-15
CY1108980T1 (el) 2014-07-02
FR2811572A1 (fr) 2002-01-18
JP2004503594A (ja) 2004-02-05
US20030109493A1 (en) 2003-06-12
JP4960568B2 (ja) 2012-06-27
ES2322794T3 (es) 2009-06-29
DK1301192T3 (da) 2009-05-18
ATE421326T1 (de) 2009-02-15
AU2001276437A1 (en) 2002-01-30
WO2002005826A1 (fr) 2002-01-24
FR2811572B1 (fr) 2003-04-18
US6930098B2 (en) 2005-08-16
PT1301192E (pt) 2009-04-24
EP1301192A1 (de) 2003-04-16
EP1301192B1 (de) 2009-01-21
CA2416369A1 (fr) 2002-01-24

Similar Documents

Publication Publication Date Title
DE60204322D1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE60223262D1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE69936102D1 (de) Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
ATE337780T1 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE301995T1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
ATE260653T1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
CY1108980T1 (el) Χρηση πολυσουλφωμενων κυκλοδεξτρινων για τη θεραπεια της αρθριτιδας
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
DE60219940D1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
DE60105053D1 (de) Zusammensetzungen zur behandlung von gewebe
DE60220825D1 (de) Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE50200757D1 (de) Verwendung von tryptophan-derivaten zur spezifischen zytostatischen behandlung von serotonin-produzierenden tumoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition